Immunotherapy is usually used for advanced patients, and some patients can receive immunotherapy combined with targeted therapy, depending on the condition.
Liver cancer usually refers to primary liver cancer, which is the 4th most common malignant tumor and the 2nd leading cause of death in China, and the most common one is hepatocellular carcinoma. Early-stage liver cancer patients prefer surgical treatment, while intermediate and advanced liver cancer patients need to choose comprehensive treatment plan according to their conditions.
Immunotherapy is an important treatment for intermediate and advanced liver cancer and can be used as a combination of radiotherapy/targeted therapy.
Some studies say that in neoadjuvant therapy, strategies such as immunotherapy combined with targeted drugs, monotherapy or combination therapy of immunotherapy are used in preoperative or perioperative treatment of liver cancer that can be surgically resected, which is expected to further improve the efficacy of surgery. And the single or combined treatment of chemotherapy, targeted therapy and immunotherapy can also be chosen after surgery according to the situation.
It is recommended to go to regular hospitals to evaluate the condition, follow the doctor’s instructions to cooperate with the treatment, and choose the appropriate program to avoid delaying the condition.